ASTHMA SPACERS MARKET ANALYSIS

The global asthma spacer market is estimated to be valued at US$ 1.86 Billion in 2023 and is expected to exhibit a CAGR of 6.7% during the forecast period (2023-2030).

Analysts’ Views on Global Asthma Spacer Market:

The global use of asthma spacers is currently expanding due to increased awareness and product effectiveness. Asthma spacers, also known as inhaler chambers, are devices that help improve the delivery of medication to the lungs by reducing the amount of medication that is lost in the mouth and throat. They are particularly beneficial for children and elderly individuals who may have difficulty coordinating their breathing with inhaler use. The growing adoption of asthma spacers not only enhances medication efficacy but also promotes better asthma management and control worldwide. In addition, asthma spacers have been found to reduce the risk of side effects associated with inhaler use, such as oral thrush and hoarseness. Furthermore, their compact and portable design makes them convenient for use in various settings, allowing individuals to effectively manage their asthma symptoms on the go.

Figure 1. Global Asthma Spacer Market Share (%), By Spacer Type, 2023

Global Asthma Spacer Market– Drivers

Increasing incidence of asthma patients globally: The prevalence of asthma in children was found to have decreased in low-income countries but increased in lower-middle-income countries. The prevalence in upper-middle and high-income countries was stable, found the Global Asthma Network (GAN) study, which shows how the worldwide burden of children’s asthma symptoms is changing. The University of Auckland, with partners including the London School of Hygiene & Tropical Medicine (LSHTM), conducted a research that included nearly 120,000 children and adolescents from 27 centers in 14 countries in phase 1. And, the findings also imply that asthma is a disease of Westernisation, with rates rising as countries with low and moderate incomes grow more Westernised. There is an urgent need for improved asthma management globally and better access to inexpensive asthma medicines.

Figure 2. Global Asthma Spacer Market Share (%), By Region, 2023

Global Asthma Spacer Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global asthma spacer market over the forecast period. North America is estimated to hold 47.8% of the market share in 2023. The global asthma spacer market is expected to witness significant growth in the near future, driven by the increase in the patient pool in the asthma. In 2019, around 7.8 percent of the population of the U.S. currently had asthma. Asthma is more common among females and children aged 5 to 14 years.

Global Asthma Spacer Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, are facing problems with the transportation of things from one place to another.

Global Asthma Spacer Market Segmentation:

The global asthma spacer market is segmented into spacer type, distribution channel, and region.

• By spacer type, the market is segmented into volumatic, aerochamber, inspirEase, optichamber, and others. Out of which, the volumatic asthma spacer is expected to hold a dominant position in the global asthma spacer market during the forecast period, and this is attributed to the easy of use of the product.
• By distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. Out of which, retail pharmacy is expected to dominate the market over the forecast period, and this is attributed to the easy availability of the product from the nearby retail pharmacy.

Among all the segmentation, the spacer type segment is expected to dominate the market over the forecast period, and this is attributed to the increasing preference of asthma spacers by patient rather than the use of asthma inhaler.

Global Asthma Spacer Market- Cross Sectional Analysis:

The market's key players are focusing on the development of asthma spacers, considering the current challenges associated with the inhaler and asthma spacer. These challenges include issues such as improper inhaler technique leading to inadequate medication delivery and difficulties in cleaning and maintaining the asthma spacer. By addressing these challenges, the key players aim to enhance the effectiveness and convenience of asthma treatment for patients. In addition, the development of asthma spacers also aims to improve patient adherence to medication regimens. Studies have shown that using a spacer can significantly increase the amount of medication delivered to the lungs, reducing the risk of asthma exacerbations and improving overall asthma control. Additionally, technological developments are being made to provide more portable and user-friendly asthma spacers, enabling patients to take them with them wherever they go for on-the-go relief.  

Global Asthma Spacer Market: Key Developments

In September 2022, CanadaPharmacyOnline.com offers the over-the-counter aerosol chamber (inhaler device mask) for pets. Owners now don't need a prescription for their pet to purchase the product from Canada. However, it is recommended that owners only purchase an aerosol chamber for pets to treat and control pet asthma if the owner’s veterinarian prescribes it. It is used with metered dose aerosol inhalers such as Flovent and Albuterol for pets, which are prescribed by the owner’s vet.

Global Asthma Spacer Market: Key Trends

• Introduction of new asthma spacer with advanced technology: The integration of new technology in the upcoming asthma spacer will globally expand the market over the forecast period. The integration will improve the effectiveness and convenience of asthma treatment. Additionally, the incorporation of advanced sensors and wireless connectivity will enable real-time monitoring of medication usage and provide valuable insights to both patients and healthcare providers. This enhanced functionality will not only enhance patient adherence to treatment plans but also facilitate personalized care and remote monitoring, ultimately leading to better asthma management outcomes. By having real-time monitoring of medication usage, patients can receive timely reminders and alerts for taking their medication, ensuring they never miss a dose. Moreover, healthcare providers can remotely track their patients' progress and make necessary adjustments to their treatment plans, reducing the need for frequent in-person visits and improving overall efficiency in asthma management.

Global Asthma Spacer Market: Restraint

• Unavailability of funding and investment for the product expansion: Currently, there's very little investment and funding available for the expansion of the asthma spacer product, due to which the patient pool is not able to access the benefits of this innovative medical device. The lack of investment and funding has hindered the production and distribution of the asthma spacer product, limiting its availability to a larger population. Consequently, many individuals suffering from asthma are unable to reap the advantages offered by this groundbreaking medical device.
• Key players focusing on investment and funding strategies for the advancement of products with safety and cost-effectiveness, which is expected to drive market growth over the forecast period.
• Counterbalance: The market players need to be made more aware of the increasing prevalence of asthma and respiratory disorders worldwide. The growing awareness among the key market players will make them aware of the need for effective medication and its delivery, as well as the advancement of spacer designed technology, which in turn will influence the market players operating in the global asthma spacer market to take an active part in making the investments.

Global Asthma Spacer Market - Key Players

Major players operating in the global asthma spacer market include Trudell Medical International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V, GlaxoSmithKline Plc., Lupin, Medical Developments International, Visiomed Group Ltd., Cipla Inc., Clement Clarke International Ltd., Rossmax International Ltd., Luckys Pharma, Mediacare Equipments (India) Pvt. Ltd., Asia Connection Co., Ltd., and Laboratoire Protecsom SAS.

*Definition: People with asthma often use inhalers (also called puffers) to take their medications. A spacer (also sometimes called a holding chamber) is a device that makes using an inhaler easier and more effective. It attaches to the inhaler on one end and to a mouthpiece or mask on the other end. When the medication from the inhaler is released into the spacer, it's held inside until it's slowly inhaled through the mouthpiece or mask. It doesn't require the special coordination that the use of an inhaler alone requires. A spacer also helps deliver the medication to the airways instead of the mouth and throat, where it can work better with fewer side effects.